CD200 and breast carcinoma: Using a transplantable EMT6 mouse breast cancer line CD200 expression, by tumor cells or host, increased local tumor growth and metastasis to DLN [6], [7], which was abolished by neutralizing antibody to CD200, or following growth in mice lacking the primary inhibitory receptor for CD200 (CD200R1KO mice).